Navigation Links
Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
Date:10/10/2007

International Conference on Molecular

Targets and Therapeutics at Moscone Center West in San Francisco,

California.

-- #C10 -- A poster presentation of preclinical data focused on tumor

growth inhibition of NKTR-102 in mouse xenograft models of colorectal,

lung and breast cancer;

-- #C157 -- A poster presentation of preclinical data focused on the

pharmacokinetics and pharmacodynamics of the active metabolite of

irinotecan following administration of NKTR-102 in mouse xenograft models

of lung and colorectal cancer.

The AACR-NCI-EORTC International Conference on Molecular Targets and Therapeutics Conference is an annual meeting of the American Association of Cancer Research (AACR), the National Cancer Institute (NCI) and the European Organization for Research and Treatment of Cancer (EORTC). More information

about the conference is available on the American Association of Cancer Research's website at:

http://www.aacr.org/home/scientists/meetings--workshops/molecular-targe ts-

and-cancer-therapeutics.aspx

About NKTR-102

Nektar is developing NKTR-102, a PEGylated form of irinotecan, which was invented by Nektar using its world-leading small molecule PEGylation technology platform. The product is currently in Phase 1 clinical development. Irinotecan is an important chemotherapeutic agent used for the treatment of solid tumors, including colorectal and lung cancers. By applying Nektar's small molecule PEGylation technology to irinotecan, NKTR-102 may prove to be a more powerful and tolerable anti-tumor agent.

More information on NKTR-102 and downloadable presentations of data for NKTR-102 are available at:

http://www.nektar.com/wt/page/nktr102media

Nektar PEGylation Platform

Nektar PEGyla
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
2. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
3. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
4. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
5. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
6. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
7. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
8. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
9. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
10. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
11. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)...  The U.S. Department of Health and Human Services ... (UH) Case Medical Center Seidman Cancer Center totaling $4.7 ... improving care for patients with complex cancer. ... a unique model developed at UH to enhance care ... or demonstrated need for high health care utilization.  ...
(Date:7/10/2014)... Yesterday, former Congressman Patrick Kennedy ... facility. Rep. Kennedy and Dick Moberg ... research in neurological disease and treatment. ... Garen Staglin , created One Mind, a ... that will radically accelerate the development and implementation ...
(Date:7/10/2014)... 2014  Decision Resources Group finds that while ... specialists are willing to prescribe Durata,s Dalvance (dalbavancin) ... as OPAT, approximately two-thirds of the respondents reported ... hospital inpatients. However, our findings indicate that nearly ... on OPAT following hospital discharge, and most are ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... (LSE: SHP, NASDAQ: SHPGY ), the global ... agreement with the Center for Drug Evaluation and Research ... to conduct additional clinical trials to confirm the clinical ... 1996 under Subpart H (an accelerated approval process) for ...
...   Remedi SeniorCare , one of the nation,s ... executive Corey Gauff as its new senior vice ... In his new position, Gauff will be responsible ... driving growth via Remedi,s innovative offerings, including the ...
Cached Medicine Technology:ProAmatine® (midodrine HCl) Update: Path Forward Agreed 2ProAmatine® (midodrine HCl) Update: Path Forward Agreed 3ProAmatine® (midodrine HCl) Update: Path Forward Agreed 4Remedi SeniorCare® Appoints Corey Gauff SVP of Sales and Account Management 2
(Date:7/12/2014)... Wright & Schulte LLC has filed a ... subsidiary of Johnson & Johnson, on behalf of an Ohio ... a metal-on-metal DePuy Pinnacle hip replacement and had to undergo ... implant. The DePuy hip lawsuit was filed July 7, 2014, ... No. 3:14-cv-2427) where DePuy Pinnacle Hip lawsuit litigation is ...
(Date:7/12/2014)... Warminster, PA (PRWEB) July 12, 2014 ... Paddock covering a variety of men’s health questions. ... issues specific to men, why women live longer than ... article, Men's Health Made Simple featured on ... can get a hernia at any age. If you ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Utah Valley ... of startups, with awards being bestowed to companies in ... Utah’s outstanding entrepreneur community with recognition for new ideas ... model with incoming revenue. , 25 Under 5 highlights ... state that are under 5 years old. Award recipients ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 A recent article ... provides a trio of suggestions for those seeking cosmetic ... days are rapidly approaching and the heat begins to enliven ... to their summer clothing, realizing that they didn’t work out ... , This can cause a sudden surge of people eager ...
(Date:7/12/2014)... 2014 Wright & Schulte LLC, an experienced ... For Men Lawsuits (case #59776/2014), announces they have launched ... that allege the popular hair dye, Just For Men, has ... face, neck and other areas. In addition to detailing symptoms ... burns , the advertisements being run by Wright & Schulte ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Best Summer Cosmetic Surgeries Revealed in Article By Seattle Plastic Surgeon 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4
... it or lose it, principle at work, one expert says ... may cut down on a man,s chances of developing erectile ... any other part of the body. It,s what we in ... it, concept," said Dr. Hossein Sadeghi-Nejad, an associate professor of ...
... Senator Specter to Reconsider and Support Bill that,Stops Cuts ... July 3 Gridlock has,paralyzed the U.S. Senate, derailing ... percent cut to doctors who treat Medicare patients, kept,Medicare ... that,44 million Americans depend on., Last week, Senator ...
... National and regional healthcare,leaders will convene in Mendocino County ... Patient Care in 2008.", "Ultimately we want to ... medical record software and by enabling the exchange,of clinical ... of Redwood MedNet, the conference host., The conference ...
... be inducted into the 2008 American Orthopaedic Society for Sports Medicine ... Meeting in Orlando. , ... Orlando, Florida (PRWEB) July ... be inducted into the 2008 American Orthopaedic Society for Sports ...
... representing doctors and beneficiaries criticize Senators,Hutchison and Cornyn ... and,improve Medicare, AUSTIN, Texas, July 3 ... Association to urge Senators Kay Bailey,Hutchison and John ... that,would stop a 10.6 percent cut to doctors ...
... older drugs as good as newer ones, study ... -- Taking prescription medications can help reduce violent ... , It included 1,445 schizophrenia patients randomly selected ... perphenanize, quetiapine, risperidone or ziprasidone. , Patient violence ...
Cached Medicine News:Health News:Lots of Sex May Prevent Erectile Dysfunction 2Health News:Pennsylvania Medical Society and AARP Criticize Senator Specter for Blocking Bill to Protect Access to Doctors and Improve Medicare 2Health News:Improving Healthcare in Rural Northern California Goal of One-Day Conference of National and State Healthcare Leaders 2Health News:Paolo Aglietti, MD, President of the International Society of Knee Surgery and Arthroscopy, Inducted into Sports Medicine Hall of Fame 2Health News:AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare 2Health News:AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare 3Health News:Medication Reduces Violence in Some Schizophrenics 2
... laboratories to work more efficiently has ... for innovative solutions. With the COBAS ... on-board measurement technologies, robotic handling of ... This supports the very broad menu ...
... Compact Size , The ADVIA 1200 system features ... in any size laboratory. , , Standardization as ... 1200 system uses the same reagents, calibrators and controls ... and is based on the same proven reliability. , ...
... Stryker Mainstay® ZIP Anchor is a family ... different sizes and suture options. The ZIP ... and 4.5mm size with either one strand ... #5 suture. Needles are attached to each ...
... Stryker BioZip Suture Anchor is a unique double ... BioZip is made from Poly-L Lactic Acid (PLLA) ... Needles are attached to the suture ends for ... arthroscopic repairs. The trocar tip inserter allows insertion ...
Medicine Products: